Near fatal stent thrombosis in an aneurysmatic RCX as first manifestation of heparin induced thrombocytopenia (HIT) without thrombocytopenia.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
31 12 2021
Historique:
received: 21 06 2021
accepted: 21 12 2021
entrez: 1 1 2022
pubmed: 2 1 2022
medline: 1 2 2022
Statut: epublish

Résumé

Thrombosis resulting from heparin-induced thrombocytopenia (HIT) occurs in about 2% of patients without a significant decrease in platelet counts. We report on such a near fatal thrombotic event caused by coronary intervention. A supposedly "completely healthy" 53-year-old patient was admitted to hospital with covered rupture of an aneurysm of the Aorta descendens. He was successfully operated on and underwent coronary angiography due to NSTEMI six days later. Immediately after intervention of a 90% RCX stenosis he developed ventricular flutter, was defibrillated, and re-angiography showed partial occlusion of the RCX stent. Lots of white thrombi could be retrieved by aspiration catheter and gave reason for a HIT without thrombocytopenia. The detection of platelet factor 4/heparin complex antibodies by immunoassay supported and the subsequent Heparin Induced Platelet Activation Assay proved this diagnosis. The clinical event of an acute stent thrombosis should alarm the interventional team to the diagnosis of HIT even with a normal platelet count.

Sections du résumé

BACKGROUND
Thrombosis resulting from heparin-induced thrombocytopenia (HIT) occurs in about 2% of patients without a significant decrease in platelet counts. We report on such a near fatal thrombotic event caused by coronary intervention.
CASE PRESENTATION
A supposedly "completely healthy" 53-year-old patient was admitted to hospital with covered rupture of an aneurysm of the Aorta descendens. He was successfully operated on and underwent coronary angiography due to NSTEMI six days later. Immediately after intervention of a 90% RCX stenosis he developed ventricular flutter, was defibrillated, and re-angiography showed partial occlusion of the RCX stent. Lots of white thrombi could be retrieved by aspiration catheter and gave reason for a HIT without thrombocytopenia. The detection of platelet factor 4/heparin complex antibodies by immunoassay supported and the subsequent Heparin Induced Platelet Activation Assay proved this diagnosis.
CONCLUSIONS
The clinical event of an acute stent thrombosis should alarm the interventional team to the diagnosis of HIT even with a normal platelet count.

Identifiants

pubmed: 34972517
doi: 10.1186/s12872-021-02442-3
pii: 10.1186/s12872-021-02442-3
pmc: PMC8720211
doi:

Substances chimiques

Anticoagulants 0
Autoantibodies 0
PF4 protein, human 0
Platelet Factor 4 37270-94-3
Heparin 9005-49-6

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

624

Informations de copyright

© 2021. The Author(s).

Références

J Thromb Haemost. 2010 Jan;8(1):30-6
pubmed: 19793190
N Engl J Med. 2001 Apr 26;344(17):1286-92
pubmed: 11320387
J Thromb Haemost. 2010 Dec;8(12):2642-50
pubmed: 20854372
Virchows Arch. 1998 Jun;432(6):541-6
pubmed: 9672196
Am J Med. 1996 Nov;101(5):502-7
pubmed: 8948273
Clin Case Rep. 2020 Nov 07;9(1):90-92
pubmed: 33489138
Thromb Haemost. 2005 Jul;94(1):132-5
pubmed: 16113796
Blood. 2000 Sep 1;96(5):1703-8
pubmed: 10961867
Thromb Res. 2016 Nov;147:64-71
pubmed: 27689317
Eur Heart J Case Rep. 2018 Nov 26;2(4):yty138
pubmed: 31020214
J Thromb Haemost. 2007 Aug;5(8):1666-73
pubmed: 17488345
N Engl J Med. 2015 Jul 16;373(3):252-61
pubmed: 26176382
Eur Heart J. 2016 Apr 14;37(15):1208-16
pubmed: 26757787
Am J Case Rep. 2019 May 28;20:753-757
pubmed: 31133634
Int Heart J. 2016 Dec 2;57(6):763-765
pubmed: 27818479
Blood. 2005 Oct 15;106(8):2710-5
pubmed: 15985543
Blood. 2006 Mar 15;107(6):2346-53
pubmed: 16304054
Blood. 2018 Aug 16;132(7):727-734
pubmed: 29914979
Clin Cardiol. 2018 Dec;41(12):1521-1526
pubmed: 30144122

Auteurs

Marc Zoller (M)

Intensive Care Unit, DRK Kliniken Berlin Köpenick, Berlin, Germany.

Iskandar Atmowihardjo (I)

Medizinische Klinik Kardiologie, DRK Kliniken Berlin Köpenick, S.-Allende-Str. 2-8, Berlin, 12559, Germany.

Jeanette Huch (J)

Medizinische Klinik Kardiologie, DRK Kliniken Berlin Köpenick, S.-Allende-Str. 2-8, Berlin, 12559, Germany.

Ines Albrecht (I)

Medizinische Klinik Kardiologie, DRK Kliniken Berlin Köpenick, S.-Allende-Str. 2-8, Berlin, 12559, Germany.

Dirk Habedank (D)

Medizinische Klinik Kardiologie, DRK Kliniken Berlin Köpenick, S.-Allende-Str. 2-8, Berlin, 12559, Germany. d.habedank@drk-kliniken-berlin.de.
Medizinische Klinik und Poliklinik B, University Hospital Greifswald, Greifswald, Germany. d.habedank@drk-kliniken-berlin.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH